Injective gains SEC approval for transfer agent status: INJ gains momentum

Traders Union
All News
Crypto
Injective jumps 7.07% today to $8.15

Highlights

Injective becomes the first layer 1 blockchain registered as a transfer agent by the SEC, creating new opportunities for regulated tokenized asset issuance.
Injective is beginning development of quantum-resistant infrastructure with a view to long-term security, though technical details and timing remain undisclosed.
INJ trades at $8.15 after gaining 7.07%, supported by bullish momentum and most indicators, with price expected to hold within the $7.6 to $8.55 range over the next 2 to 3 days.

Sec registration as transfer agent drives institutional demand

Injective has achieved registration as a transfer agent by the SEC, becoming the first layer 1 blockchain to obtain this regulatory approval, according to Cryptowisser. This step unlocks opportunities for regulated tokenized asset infrastructure and positions Injective to attract institutional capital seeking compliance-ready networks, which has provoked heightened demand for the asset. Alongside this, the network is starting to develop quantum-resistant infrastructure, as reported by Cryptobriefing, signaling a long-run focus on security and future-proofing even as technical specifics and delivery timelines remain undisclosed.

Buyer control as INJ holds above multiple technical supports

INJ/USD is establishing a technical floor at $7.56, which aligns with the Ichimoku Kijun level. The asset trades above the MA-20 and MA-50 on the h1 chart, while also maintaining a strong buffer over the MA-200. Momentum indicators reflect supportive conditions, with MACD and Bull/Bear Power both highlighting buyer dominance. RSI and CCI are also indicating robust buying strength with no clear overbought signs, though both the Stochastic RSI and Awesome Oscillator remain neutral. ADX is positioned as neutral as well, confirming that momentum is not excessively directional yet.

Sideways bias as resistance and support define short-term range

Over the next 2–3 trading days, INJ is projected to move within a $7.60 to $8.55 volatility band relative to current levels. The most probable scenario is that price will remain contained in this sideways corridor. If INJ can sustain a clear break above the $8.55 resistance, an extended rally may unfold. Conversely, a reversal below $7.60 would shift the outlook to bearish, though this is a low-probability risk under current conditions.

Viktoras Karapetjanc, Traders Union expert, sees fresh SEC registration as a strong regulator-driven catalyst for Injective. He believes institutional and compliance-focused interest will remain high in the near term, with fundamentals now supporting robust sentiment. Technicals align with this momentum, keeping risk of deeper reversal low as long as price holds above $7.60. "This regulatory milestone puts Injective in a clear leadership position, and I expect further upside as buyers stay in control."

Previously, analysts noted that Injective’s bullish momentum was anchored by growing institutional interest and ongoing protocol advancements. The current registration as a transfer agent, combined with quantum-resistance measures, adds a regulatory and security dimension to the narrative, with traders advised to monitor $8.55 as a breakout level that could define the next directional move.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.